Black Book Report Highlights Total Cost of Ownership and Cybersecurity Threats as Primary Factors Influencing Shift Toward Affordable, Cloud-Based EHR Solutions TAMPA, FL / ACCESS Newswire / July 30, ...

MESA, ARIZONA / ACCESS Newswire / July 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is redefining the future of preventive healthcare with its cutting-edge AI Facial Age-Based Health Risk ...

Ariessence Pure PDGF+ is now available at Rubinstein Plastic Surgery Center, offering topical and injectable applications to ...

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of ...

The Mammography Market is a dynamic segment within the global medical imaging industry, focused on the early detection and ...

Eramol, a UK-based pharmaceutical contract development and manufacturing organisation (CDMO), is pleased to announce ...

The Global Cosmetic Surgery Market achieved a valuation of $60.22 Billion in 2024 and is anticipated to exceed $136.55 ...

Edwards’ KONECT RESILIA Aortic Valved Conduit Receives CE Mark FOR COMPLEX AORTIC VALVE SURGERIESNEWBURY, July 25 2025 – Edwards Lifesciences today announced that it has received CE Mark for its ...

NEW YORK CITY, NEW YORK / ACCESS Newswire / July 30, 2025 / AI Maverick Intel Inc. (OTC:BINP), a technology-forward company focused on transforming how businesses acquire and engage customers through ...

Topical Ketamir-2 significantly reduced both acute and inflammatory pain behaviors in animals, demonstrating rapid onset, durable effect, and comparable efficacy to injected morphine across both pain ...

Terrance Cole's First Test as AdministratorMMJ BioPharma Cultivation's case exposes DEA's Diversion Control Division as a cartel of obstructionists who have abandoned science, betrayed public trust, ...

Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma Designation granted for IgG1-based GPRC5D monoclonal antibody for the potential treatment ...